Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

Delayed Data
As of Nov 27
 +0.91 / +0.31%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Biogen have a median target of 384.00, with a high estimate of 450.00 and a low estimate of 266.00. The median estimate represents a +30.96% increase from the last price of 293.21.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Biogen. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.65%
Growthannually 19.65%


Growthquarterly -2.90%
Growthannually 9.41%
Key to the earnings and sales forecast charts.